US Stock MarketDetailed Quotes

NAMS NewAmsterdam Pharma

Watchlist
  • 24.590
  • +0.470+1.95%
Close Nov 11 16:00 ET
  • 24.590
  • 0.0000.00%
Post 20:02 ET
2.27BMarket Cap-11126P/E (TTM)

NewAmsterdam Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NewAmsterdam Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 0.000 --
-- 2024/Q4 -- / 1.602M --
-- 2024/Q3 27.126M / 1.705M --
-- 2024/Q2 2.085M / 1.109M --
-- 2024/Q1 1.304M / 1.607M --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 1.602M--
--2024/Q327.126M / 1.705M--
--2024/Q22.085M / 1.109M--
--2024/Q11.304M / 1.607M--

Unlock Free Earnings Estimates

NewAmsterdam Pharma Earnings Reports

  • 10-Q: Quarterly report

    Nov 6 21:02

  • 20-F/A: Registration statement / Annual report / Transition report (Amendment)

    Oct 28 20:04

  • 10-Q: Q2 2024 Earnings Report

    Aug 7 20:01

  • 10-Q: Quarterly report

    May 9 04:39

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 31, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data